781614301	781614301	CD	B-NP	O
|	|	NN	I-NP	O
LM	LM	NN	I-NP	O
|	|	NN	I-NP	O
87129529	87129529	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
6023998	6023998	CD	B-NP	O
|	|	CC	I-NP	O
2/11/2006	2/11/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
hypoglycemia	hypoglycemia	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/4/2006	6/4/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/17/2006	8/17/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
SAPIENZA	SAPIENZA	NNP	B-NP	O
,	,	,	O	O
LORENZO	LORENZO	NNP	B-NP	O
EMERY	EMERY	NNP	I-NP	O
007-07-09-4	007-07-09-4	CD	I-NP	O
Mont	Mont	NNP	I-NP	O
Norfence	Norfence	NNP	I-NP	O
Troitvirgri	Troitvirgri	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
4/8/06	4/8/06	CD	B-NP	O
AT	AT	NN	I-NP	O
08	08	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
SCANTLING	SCANTLING	NNP	B-NP	O
,	,	,	O	O
AMBROSE	AMBROSE	NNP	B-NP	O
E.	E.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
J.D.	J.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ENTERIC	ENTERIC	NNP	B-NP	O
COATED	COATED	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
81	81	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
ATENOLOL	ATENOLOL	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
COLACE	COLACE	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DOCUSATE	DOCUSATE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
LASIX	LASIX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
80	80	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
11/26/06	11/26/06	CD	B-NP	O
by	by	IN	B-PP	O
BAILIFF	BAILIFF	NN	B-NP	B-protein
,	,	,	O	O
HARVEY	HARVEY	NN	B-NP	O
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LASIX	LASIX	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
226683855	226683855	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
POSSIBLE	POSSIBLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
Sulfa	Sulfa	NN	B-NP	O
;	;	:	O	O
reactions	reaction	NNS	B-NP	O
are	be	VBP	B-VP	O
Rash	Rash	NNP	B-NP	O
,	,	,	O	O
Swelling	Swelling	NNP	B-NP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	B-protein
SYNTHROID	SYNTHROID	NN	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
LEVOTHYROXINE	LEVOTHYROXINE	NNP	I-NP	I-protein
SODIUM	SODIUM	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
125	125	CD	I-NP	I-protein
MCG	MCG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
OXYCODONE	OXYCODONE	NNP	I-NP	I-protein
5-10	5-10	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
Q6H	Q6H	NNP	I-NP	I-protein
PRN	PRN	NNP	I-NP	I-protein
Pain	Pain	NNP	I-NP	I-protein
MULTIVITAMIN	MULTIVITAMIN	NNP	I-NP	I-protein
THERAPEUTIC	THERAPEUTIC	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
THERAPEUTIC	THERAPEUTIC	NNP	I-NP	I-protein
MULTIVI	MULTIVI	NNP	I-NP	I-protein
...	...	:	O	I-protein
-RRB-	-RRB-	SYM	B-NP	I-protein
1	1	CD	I-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
11/26/06	11/26/06	CD	B-NP	O
by	by	IN	B-PP	O
DAUB	DAUB	NN	B-NP	B-protein
,	,	,	O	O
TRENTON	TRENTON	NN	B-NP	B-DNA
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
SIMVASTATIN	SIMVASTATIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
137582571	137582571	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
NIACIN	NIACIN	NN	B-NP	B-protein
,	,	,	O	O
VIT	VIT	NN	B-NP	B-protein
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
&	&	CC	I-NP	O
SIMVASTATIN	SIMVASTATIN	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
AMLODIPINE	AMLODIPINE	NN	I-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

IMDUR	IMDUR	NN	B-NP	O
ER	ER	NN	I-NP	B-protein
-LRB-	-LRB-	NNP	I-NP	O
ISOSORBIDE	ISOSORBIDE	NNP	I-NP	O
MONONITRATE	MONONITRATE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SR	SR	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
60	60	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
Food/Drug	Food/Drug	NN	I-NP	O
Interaction	Interaction	NN	I-NP	O
Instruction	Instruction	NN	I-NP	O
Give	Give	NN	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-PP	O
food	food	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
BETAMETHASONE	BETAMETHASONE	NN	I-NP	O
VALERATE	VALERATE	NN	I-NP	O
0.1	0.1	CD	B-NP	O
%	%	NN	I-NP	O
TOPICAL	TOPICAL	NN	I-NP	O
TP	TP	NN	I-NP	O
BID	BID	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
23	23	CD	B-NP	O
HYZAAR	HYZAAR	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
25	25	CD	I-NP	O
MG/100	MG/100	NN	I-NP	O
MG	MG	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
HYDROCHLORTHIAZIDE	HYDROCHLORTHIAZIDE	NN	I-NP	O
25M	25M	NN	I-NP	O
...	...	:	O	O
-RRB-	-RRB-	SYM	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	B-protein
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
11/26/06	11/26/06	CD	B-NP	O
by	by	IN	B-PP	O
BRADFORD	BRADFORD	NN	B-NP	O
,	,	,	O	O
PHIL	PHIL	NN	B-NP	B-protein
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
HYZAAR	HYZAAR	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	I-NP	O
25	25	CD	I-NP	O
MG/100	MG/100	NN	I-NP	O
MG	MG	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
934862742	934862742	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
PROBABLE	PROBABLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
Sulfa	Sulfa	NN	B-NP	O
;	;	:	O	O
reactions	reaction	NNS	B-NP	O
are	be	VBP	B-VP	O
Rash	Rash	NNP	B-NP	O
,	,	,	O	O
Swelling	Swelling	NNP	B-NP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
tolerates	tolerate	VBZ	B-VP	O
Number	Number	NNP	B-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
2345	2345	CD	B-NP	O
LIPITOR	LIPITOR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ATORVASTATIN	ATORVASTATIN	NN	I-NP	O
-RRB-	-RRB-	,	O	O
40	40	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
4/8/06	4/8/06	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NN	B-NP	O
SERIOUS	SERIOUS	NN	I-NP	O
INTERACTION	INTERACTION	NN	I-NP	O
:	:	:	O	O
NIACIN	NIACIN	NN	B-NP	B-protein
,	,	,	O	O
VIT	VIT	NN	B-NP	B-protein
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
&	&	CC	I-NP	O
ATORVASTATIN	ATORVASTATIN	NN	I-NP	O
CALCIUM	CALCIUM	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
mda	mda	NN	B-NP	B-DNA
OMEPRAZOLE	OMEPRAZOLE	NN	I-NP	I-DNA
20	20	CD	B-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
DAILY	DAILY	NNP	I-NP	I-DNA
GLIPIZIDE	GLIPIZIDE	NNP	I-NP	I-DNA
5	5	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
DAILY	DAILY	NNP	I-NP	I-DNA
Instructions	Instruction	NNPS	I-NP	I-DNA
:	:	:	O	O
start	start	VB	B-VP	O
when	when	WRB	B-ADVP	O
your	your	PRP$	B-NP	O
blood	blood	NN	I-NP	O
sugars	sugar	NNS	I-NP	O
are	be	VBP	B-VP	O
>	>	SYM	B-ADJP	O
100	100	CD	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
4/8/06	4/8/06	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
GLIPIZIDE	GLIPIZIDE	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	O
799306707	799306707	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
POSSIBLE	POSSIBLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
Sulfa	Sulfa	NN	B-NP	O
;	;	:	O	O
reactions	reaction	NNS	B-NP	O
are	be	VBP	B-VP	O
Rash	Rash	NNP	B-NP	O
,	,	,	O	O
Swelling	Swelling	NNP	B-NP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
unclear	unclear	JJ	B-ADJP	O
if	if	IN	B-SBAR	O
has	have	VBZ	O	O
sulfa	sulfa	NN	B-NP	O
allergy	allergy	NN	I-NP	O
,	,	,	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
COLCHICINE	COLCHICINE	NN	B-NP	B-protein
0.6	0.6	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
EVERY	EVERY	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DAY	DAY	NNP	I-NP	O
DIET	DIET	NNP	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
should	should	MD	B-VP	O
measure	measure	VB	I-VP	O
weight	weight	NN	B-NP	O
daily	daily	JJ	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
1800	1800	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Ericson	Ericson	NNP	I-NP	O
2/11	2/11	CD	I-NP	O
@	@	IN	B-PP	O
9	9	CD	B-NP	O
:	:	SYM	I-NP	O
45	45	CD	I-NP	O
am	am	NN	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
ALLERGY	ALLERGY	NNP	B-NP	O
:	:	:	O	O
Demerol	Demerol	NNP	B-NP	O
,	,	,	O	O
Sulfa	Sulfa	NNP	B-NP	O
,	,	,	O	O
METFORMIN	METFORMIN	NNP	B-NP	O
HCL	HCL	NNP	I-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
hypoglycemia	hypoglycemia	NN	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NN	B-NP	O
for	for	IN	B-PP	O
Causing	Cause	VBG	B-VP	O
Admission	Admission	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
hypoglycemia	hypoglycemia	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
hypertension	hypertension	NN	I-NP	O
,	,	,	O	O
hyperchol	hyperchol	NN	B-NP	O
,	,	,	O	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
gastroesophageal	gastroesophageal	JJ	B-NP	O
reflux	reflux	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
psoriasis	psoriasis	NN	B-NP	O
,	,	,	O	O
obesity	obesity	NN	B-NP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
IV	IV	CD	I-NP	O
glucose	glucose	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
73yo	73yo	CD	B-NP	O
with	with	IN	B-PP	O
hypoglycemia	hypoglycemia	NN	B-NP	O
.	.	.	O	O

PT	PT	NN	B-NP	O
with	with	IN	B-PP	O
HTN	HTN	NN	B-NP	B-protein
with	with	IN	B-PP	O
LVH	LVH	NN	B-NP	B-protein
and	and	CC	O	O
diastolic	diastolic	JJ	B-NP	O
CHF	CHF	NN	I-NP	O
,	,	,	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
CAD	CAD	NN	B-NP	B-protein
,	,	,	O	O
hyperchol	hyperchol	NN	B-NP	O
,	,	,	O	O
recently	recently	RB	B-ADVP	O
diagnosed	diagnose	VBN	B-VP	O
with	with	IN	B-PP	O
gout	gout	NN	B-NP	O
and	and	CC	O	O
started	start	VBN	B-VP	O
on	on	IN	B-PP	O
colchicine	colchicine	NN	B-NP	O
p/w	p/w	NN	I-NP	O
hypoglycemia	hypoglycemia	NN	I-NP	O
for	for	IN	B-PP	O
1wk	1wk	NN	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
saw	see	VBD	B-VP	O
Dr.	Dr.	NNP	B-NP	O
Bergerson	Bergerson	NNP	I-NP	O
re	re	NN	I-NP	O
:	:	:	O	O
low	low	JJ	B-NP	O
FSBS	FSBS	NNP	I-NP	O
who	who	WP	B-NP	O
cut	cut	VBD	B-VP	O
the	the	DT	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
glyburide	glyburide	NN	B-NP	O
to	to	TO	B-VP	O
5bid	5bid	VB	I-VP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
week	week	NN	I-NP	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
,	,	,	O	O
nevertheless	nevertheless	RB	B-ADVP	O
,	,	,	O	O
been	be	VBN	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
maint	maint	VB	I-VP	O
a	a	DT	B-NP	O
FSBS	FSBS	NNP	I-NP	B-protein
>	>	JJR	B-NP	O
70	70	CD	I-NP	O
with	with	IN	B-PP	O
symptoms	symptom	NNS	B-NP	O
when	when	WRB	B-ADVP	O
<	<	SYM	B-NP	O
60	60	CD	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	NN	B-NP	B-protein
a1c	a1c	NN	I-NP	I-protein
recently	recently	RB	B-NP	I-protein
7.9	7.9	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

Her	Her	PRP$	B-NP	O
only	only	JJ	I-NP	O
recent	recent	JJ	I-NP	O
health	health	NN	I-NP	O
change	change	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
gout	gout	NN	B-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
R	R	NN	I-NP	B-protein
ankle	ankle	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
started	start	VBD	B-VP	O
colchicine	colchicine	NN	B-NP	O
3d	3d	NN	I-NP	O
pta	pta	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
recent	recent	JJ	I-NP	O
admission	admission	NN	I-NP	O
for	for	IN	B-PP	O
CHF	CHF	NN	B-NP	O
tx	tx	NN	I-NP	O
with	with	IN	B-PP	O
incr	incr	NN	B-NP	O
lasix	lasix	NN	I-NP	O
1wk	1wk	NN	I-NP	O
pta	pta	NN	I-NP	O
.	.	.	O	O

ROS	ROS	NN	B-NP	B-protein
pos	po	NNS	I-NP	I-protein
only	only	RB	B-ADVP	O
for	for	IN	B-PP	O
cough	cough	NN	B-NP	O
of	of	IN	B-PP	O
several	several	JJ	B-NP	O
weeks	week	NNS	I-NP	O
that	that	WDT	B-NP	O
seems	seem	VBZ	B-VP	O
to	to	TO	I-VP	O
coincide	coincide	VB	I-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
fluid	fluid	NN	I-NP	O
overload	overload	NN	I-NP	O
and	and	CC	O	O
infrequent	infrequent	JJ	B-NP	O
chills	chill	NNS	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
two	two	CD	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

*****	*****	SYM	O	O
Admission	Admission	NN	B-NP	O
Exam	Exam	NN	I-NP	O
:	:	:	O	O
96	96	CD	B-NP	O
,	,	,	I-NP	O
74	74	CD	I-NP	O
,	,	,	I-NP	O
159/76	159/76	CD	I-NP	O
,	,	,	I-NP	O
95	95	CD	I-NP	O
%	%	NN	I-NP	O
ra	ra	NN	I-NP	O
.	.	.	O	O

NAD	NAD	NN	B-NP	O
,	,	,	O	O
well	well	RB	B-VP	O
appearing	appear	VBG	I-VP	O
,	,	,	O	O
CTA	CTA	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
,	,	,	O	O
JVP	JVP	NN	B-NP	B-protein
10	10	CD	I-NP	I-protein
cm	cm	NN	I-NP	I-protein
H2O	H2O	NN	I-NP	I-protein
with	with	IN	B-PP	O
prom	prom	NN	B-NP	O
v-wave	v-wave	NN	I-NP	O
,	,	,	O	O
RRR	RRR	NN	B-NP	B-protein
With	With	IN	B-PP	O
2/6	2/6	CD	B-NP	O
SEM	SEM	NN	I-NP	O
at	at	IN	B-PP	O
RUSB	RUSB	NN	B-NP	B-protein
rad	rad	NN	I-NP	O
to	to	TO	B-PP	O
apex	apex	NN	B-NP	O
,	,	,	O	O
abd	abd	NN	B-NP	O
obese	obese	JJ	B-ADJP	O
but	but	CC	I-ADJP	O
benign	benign	JJ	I-ADJP	O
,	,	,	O	O
2/4	2/4	CD	B-NP	O
B	B	NN	I-NP	O
LE	LE	NN	I-NP	O
brawny	brawny	JJ	I-NP	O
PE	PE	NN	I-NP	O
with	with	IN	B-PP	O
L	L	NN	B-NP	O
lateral	lateral	JJ	I-NP	O
malleolus	malleolus	NN	I-NP	O
tenderness	tenderness	NN	I-NP	O
and	and	CC	O	O
slightly	slightly	RB	B-VP	O
reduced	reduce	VBN	I-VP	O
ROM	ROM	NN	B-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	O
:	:	:	O	O
NSR	NSR	NN	B-NP	B-DNA
68	68	CD	I-NP	I-DNA
,	,	,	O	O
RBBB	RBBB	NNP	B-NP	O
Labs	Labs	NNP	I-NP	O
:	:	:	O	O
u/a	u/a	NN	B-NP	O
neg	neg	NN	I-NP	O
,	,	,	O	O
cr	cr	NN	B-NP	O
1.4	1.4	CD	I-NP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
*****	*****	SYM	B-NP	O
Imp	Imp	NN	I-NP	O
:	:	:	O	O
Hypoglycemia	Hypoglycemia	NN	B-NP	O
most	most	RBS	B-ADVP	O
likely	likely	RB	I-ADVP	O
from	from	IN	B-PP	O
impair	impair	NN	B-NP	O
renal	renal	JJ	I-NP	O
clearance	clearance	NN	I-NP	O
of	of	IN	B-PP	O
glyburide	glyburide	NN	B-NP	O
.	.	.	O	O

Possibly	Possibly	RB	B-NP	O
addition	addition	NN	I-NP	O
of	of	IN	B-PP	O
colchinine/increased	colchinine/increase	VBN	B-NP	O
furosemide	furosemide	NN	I-NP	O
made	make	VBD	B-VP	O
this	this	DT	B-NP	O
worse	worse	JJR	B-ADJP	O
.	.	.	O	O

Hospital	Hospital	NNP	B-NP	O
Course	Course	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Hypoglycemia	Hypoglycemia	NN	B-NP	O
-	-	HYPH	I-NP	O
Held	Held	NN	I-NP	O
glyburide	glyburide	NN	I-NP	O
and	and	CC	O	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
low	low	JJ	B-NP	O
dose	dose	NN	I-NP	O
D10	D10	NN	I-NP	O
drip	drip	NN	I-NP	O
.	.	.	O	O

Finger	Finger	NN	B-NP	O
sticks	stick	NNS	I-NP	O
were	be	VBD	B-VP	O
checked	check	VBN	I-VP	O
every	every	DT	B-NP	O
q4	q4	NN	I-NP	O
hours	hour	NNS	I-NP	O
and	and	CC	O	O
FSBS	FSBS	NNP	B-NP	O
increased	increase	VBD	B-VP	O
to	to	TO	B-PP	O
150s	150	NNS	B-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
instructed	instruct	VBN	I-VP	O
to	to	TO	I-VP	O
eat	eat	VB	I-VP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
diet	diet	NN	I-NP	O
and	and	CC	O	O
check	check	VB	B-VP	O
her	her	PRP	B-NP	O
sugars	sugar	VBZ	B-VP	O
every	every	DT	B-NP	O
4	4	CD	I-NP	O
hours	hour	NNS	I-NP	O
and	and	CC	O	O
when	when	WRB	B-ADVP	O
they	they	PRP	B-NP	O
remain	remain	VBP	B-VP	O
>	>	SYM	B-ADJP	O
100	100	CD	B-NP	O
and	and	CC	O	O
near	near	IN	B-PP	O
200s	200s	CD	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
may	may	MD	B-VP	O
start	start	VB	I-VP	O
glipizide	glipizide	NN	B-NP	O
.	.	.	O	O

Note	Note	NNP	B-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
possible	possible	JJ	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
sulfa	sulfa	NN	B-NP	O
which	which	WDT	B-NP	O
manifest	manifest	VBP	B-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
rash	rash	NN	I-NP	O
after	after	IN	B-PP	O
taking	take	VBG	B-VP	O
an	an	DT	B-NP	O
?	?	.	O	O

allergy	allergy	NN	B-NP	O
medicine	medicine	NN	I-NP	O
.	.	.	O	O

Unlikely	Unlikely	JJ	B-ADJP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
rash	rash	NN	B-NP	O
as	as	IN	B-SBAR	O
tolerates	tolerate	VBZ	B-VP	O
lasix	lasix	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
sulfa	sulfa	NN	I-NP	O
containing	contain	VBG	B-VP	O
-RRB-	-RRB-	NN	B-NP	B-protein
.	.	.	O	O

Will	Will	MD	B-VP	O
have	have	VBP	I-VP	O
pt	pt	VB	I-VP	O
monitor	monitor	NN	B-NP	O
for	for	IN	B-PP	O
rash	rash	NN	B-NP	O
and	and	CC	I-NP	O
call	call	NN	I-NP	O
if	if	IN	B-SBAR	O
has	have	VBZ	B-VP	O
any	any	DT	B-NP	O
difficulties/prolonged	difficulties/prolonged	JJ	I-NP	O
hypoglycemia	hypoglycemia	NN	I-NP	O
.	.	.	O	O

VNA	VNA	NN	B-NP	O
services	service	NNS	I-NP	O
to	to	TO	B-VP	O
check	check	VB	I-VP	O
in	in	RP	B-PRT	O
on	on	IN	B-PP	O
patient	patient	NN	B-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
weekend	weekend	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Gout	Gout	AFX	B-NP	O
-	-	HYPH	I-NP	O
pt	pt	NN	I-NP	O
reports	report	NNS	I-NP	O
symptoms	symptom	NNS	I-NP	O
are	be	VBP	B-VP	O
much	much	RB	I-VP	O
improved	improve	VBN	I-VP	O
.	.	.	O	O

No	No	DT	B-NP	O
concern	concern	NN	I-NP	O
for	for	IN	B-PP	O
joint	joint	JJ	B-NP	O
infection	infection	NN	I-NP	O
based	base	VBN	B-VP	O
on	on	IN	B-PP	O
exam	exam	NN	B-NP	O
.	.	.	O	O

Will	Will	MD	B-VP	O
continue	continue	VB	I-VP	O
colchicine	colchicine	NN	B-NP	O
at	at	IN	B-PP	O
renal	renal	JJ	B-NP	O
dose	dose	NN	I-NP	O
and	and	CC	I-NP	O
use	use	NN	I-NP	O
narcotics	narcotic	NNS	I-NP	O
for	for	IN	B-PP	O
prn	prn	NN	B-NP	O
relief	relief	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

HTN	HTN	NN	B-NP	B-protein
-	-	HYPH	I-NP	O
cont	cont	NN	I-NP	O
home	home	NN	I-NP	O
meds	med	NNS	I-NP	O
of	of	IN	B-PP	O
ASA	ASA	NN	B-NP	O
,	,	,	O	O
lasix	lasix	NN	B-NP	O
,	,	,	O	O
statin	statin	NN	B-NP	O
,	,	,	O	O
hyzaar	hyzaar	NN	B-NP	O
,	,	,	O	O
atenolol	atenolol	NN	B-NP	O
,	,	,	O	O
norvasc	norvasc	NN	B-NP	O
4	4	CD	I-NP	O
.	.	.	O	O

CRI	CRI	NN	B-NP	B-protein
-	-	HYPH	B-PP	O
stable	stable	JJ	B-ADJP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
remained	remain	VBD	B-VP	O
at	at	IN	B-PP	O
1.4	1.4	CD	B-NP	O
and	and	CC	O	O
bBUN	bBUN	NN	B-NP	O
improved	improve	VBD	B-VP	O
from	from	IN	B-PP	O
73	73	CD	B-NP	O
to	to	TO	B-PP	O
64	64	CD	B-NP	O
with	with	IN	B-PP	O
IVFs	IVF	NNS	B-NP	B-protein
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

CHF	CHF	NNP	B-NP	O
-	-	HYPH	O	O
Cont	Cont	NNP	B-NP	O
lasix	lasix	CD	I-NP	O
at	at	IN	B-PP	O
80	80	CD	B-NP	O
as	as	IN	B-PP	O
per	per	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Rager	Rager	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
outpt	outpt	JJ	I-NP	O
cardiologist	cardiologist	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Instruct	Instruct	NN	B-NP	O
pt	pt	NN	I-NP	O
to	to	TO	B-VP	O
weigh	weigh	VB	I-VP	O
herself	herself	PRP	B-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

GERD	GERD	NN	B-NP	O
-	-	HYPH	I-NP	O
cont	cont	NN	I-NP	O
PPI	PPI	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
issues	issue	NNS	I-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Check	Check	VB	B-VP	O
your	your	PRP$	B-NP	O
blood	blood	NN	I-NP	O
sugar	sugar	NN	I-NP	O
every	every	DT	B-NP	O
4-6	4-6	CD	I-NP	O
hours	hour	NNS	I-NP	O
until	until	IN	B-SBAR	O
it	it	PRP	B-NP	O
remains	remain	VBZ	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
100	100	CD	B-NP	O
.	.	.	O	O

After	After	IN	B-SBAR	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
stable	stable	JJ	B-ADJP	O
with	with	IN	B-PP	O
blood	blood	NN	B-NP	O
sugars	sugar	NNS	I-NP	O
around	around	IN	B-PP	O
200	200	CD	B-NP	O
you	you	PRP	B-NP	O
may	may	MD	B-VP	O
begin	begin	VB	I-VP	O
glipizide	glipizide	NN	B-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
you	you	PRP	B-NP	O
develop	develop	VBP	B-VP	O
a	a	DT	B-NP	O
rash	rash	NN	I-NP	O
or	or	CC	I-NP	O
persistant	persistant	JJ	I-NP	O
hypoglycemia	hypoglycemia	NN	I-NP	O
,	,	,	O	O
call	call	NN	B-NP	O
Dr.	Dr.	NNP	I-NP	O
Batalona	Batalona	NNP	I-NP	O
or	or	CC	O	O
go	go	VB	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ED	ED	NNP	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

VNA	VNA	NN	B-NP	O
services	service	NNS	I-NP	O
for	for	IN	B-PP	O
home	home	NN	B-NP	O
eval	eval	NN	I-NP	O
and	and	CC	I-NP	O
blood	blood	NN	I-NP	B-protein
glucose	glucose	NN	I-NP	I-protein
monitoring	monitor	VBG	B-VP	I-protein
2	2	CD	B-NP	I-protein
.	.	.	O	O

recheck	recheck	VB	B-VP	O
renal	renal	JJ	B-NP	O
function	function	NN	I-NP	O
and	and	CC	I-NP	O
glucose	glucose	NN	I-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
week	week	NN	I-NP	O
,	,	,	O	O
increase	increase	VBP	B-VP	O
glipizide	glipizide	NN	B-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-NP	O
No	No	DT	I-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
AALUND	AALUND	NN	B-NP	O
,	,	,	O	O
CHARLES	CHARLES	NNP	B-NP	O
J.	J.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DG15	DG15	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
4/8/06	4/8/06	CD	I-NP	O
@	@	SYM	B-NP	O
03	03	CD	I-NP	O
:	:	SYM	I-NP	O
58	58	CD	I-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

